ロード中...

Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities

Since nivolumab significantly prolongs survival in patients with metastatic melanoma, the number of patients administered nivolumab is increasing, but only 30–40% of patients who received nivolumab monotherapy experienced objective tumor regression. Therefore, enhancing its anti-tumor immune respons...

詳細記述

保存先:
書誌詳細
出版年:Case Rep Oncol
主要な著者: Furudate, Sadanori, Fujimura, Taku, Kambayashi, Yumi, Hidaka, Takanori, Hashimoto, Akira, Aiba, Setsuya
フォーマット: Artigo
言語:Inglês
出版事項: S. Karger AG 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118831/
https://ncbi.nlm.nih.gov/pubmed/27920696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000450974
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!